Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 35 | 2025 | 220 | 9.590 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 14 | 2025 | 39 | 4.740 |
Why?
|
| Chromatin | 7 | 2025 | 186 | 1.990 |
Why?
|
| Breast Neoplasms | 12 | 2025 | 1723 | 1.630 |
Why?
|
| Nuclear Proteins | 6 | 2025 | 333 | 1.630 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2025 | 257 | 1.570 |
Why?
|
| Mitomycins | 6 | 2015 | 7 | 1.410 |
Why?
|
| Cell Line, Tumor | 25 | 2025 | 2676 | 1.350 |
Why?
|
| DNA Repair | 3 | 2025 | 198 | 1.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2019 | 968 | 1.190 |
Why?
|
| Mutation | 10 | 2025 | 1177 | 1.020 |
Why?
|
| Antineoplastic Agents | 5 | 2024 | 1019 | 0.970 |
Why?
|
| Transcriptional Activation | 4 | 2015 | 173 | 0.910 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2025 | 200 | 0.840 |
Why?
|
| Trans-Activators | 1 | 2025 | 192 | 0.840 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2022 | 3 | 0.780 |
Why?
|
| Cell Nucleus | 3 | 2020 | 383 | 0.700 |
Why?
|
| DNA Replication | 2 | 2019 | 148 | 0.690 |
Why?
|
| Signal Transduction | 8 | 2017 | 2157 | 0.690 |
Why?
|
| Electrons | 1 | 2021 | 76 | 0.670 |
Why?
|
| DNA Adducts | 3 | 2010 | 37 | 0.660 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2024 | 79 | 0.640 |
Why?
|
| Piperazines | 3 | 2025 | 120 | 0.640 |
Why?
|
| DNA, Neoplasm | 2 | 2019 | 92 | 0.630 |
Why?
|
| Neoplasms | 5 | 2015 | 1377 | 0.600 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2015 | 863 | 0.590 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 223 | 0.590 |
Why?
|
| Genes, p53 | 3 | 2024 | 27 | 0.580 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2019 | 25 | 0.580 |
Why?
|
| Humans | 34 | 2025 | 43102 | 0.560 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 495 | 0.560 |
Why?
|
| Mutant Proteins | 2 | 2015 | 51 | 0.540 |
Why?
|
| Protein Isoforms | 2 | 2018 | 139 | 0.530 |
Why?
|
| Peptides | 1 | 2020 | 372 | 0.520 |
Why?
|
| Adenosine | 2 | 2015 | 62 | 0.490 |
Why?
|
| Estrogens | 1 | 2017 | 203 | 0.480 |
Why?
|
| Imidazoles | 2 | 2025 | 142 | 0.470 |
Why?
|
| Cell Death | 5 | 2015 | 278 | 0.460 |
Why?
|
| Female | 17 | 2025 | 24698 | 0.460 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2015 | 47 | 0.450 |
Why?
|
| DNA | 4 | 2024 | 592 | 0.450 |
Why?
|
| Cell Proliferation | 5 | 2020 | 1455 | 0.440 |
Why?
|
| Protein Kinases | 3 | 2015 | 100 | 0.440 |
Why?
|
| DNA Damage | 8 | 2015 | 356 | 0.430 |
Why?
|
| Cell Cycle Proteins | 3 | 2025 | 241 | 0.420 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2014 | 41 | 0.410 |
Why?
|
| Vesicular Transport Proteins | 1 | 2014 | 48 | 0.410 |
Why?
|
| Estradiol | 2 | 2017 | 268 | 0.410 |
Why?
|
| Proteome | 1 | 2015 | 152 | 0.410 |
Why?
|
| Protein Binding | 6 | 2025 | 1082 | 0.400 |
Why?
|
| Alternative Splicing | 1 | 2014 | 94 | 0.400 |
Why?
|
| Caenorhabditis elegans | 1 | 2014 | 80 | 0.400 |
Why?
|
| Gene Knockdown Techniques | 3 | 2019 | 189 | 0.380 |
Why?
|
| Mitomycin | 3 | 2010 | 13 | 0.350 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2025 | 347 | 0.340 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2012 | 116 | 0.330 |
Why?
|
| Apoptosis | 7 | 2024 | 1568 | 0.320 |
Why?
|
| Animals | 13 | 2025 | 16992 | 0.310 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 652 | 0.290 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1070 | 0.290 |
Why?
|
| Mice | 8 | 2025 | 6644 | 0.270 |
Why?
|
| RNA, Small Interfering | 3 | 2019 | 436 | 0.240 |
Why?
|
| Phosphorylation | 3 | 2017 | 986 | 0.240 |
Why?
|
| Blotting, Western | 3 | 2015 | 883 | 0.230 |
Why?
|
| RNA Interference | 3 | 2014 | 247 | 0.230 |
Why?
|
| Lipoylation | 1 | 2025 | 17 | 0.220 |
Why?
|
| Up-Regulation | 4 | 2019 | 536 | 0.220 |
Why?
|
| Response Elements | 2 | 2020 | 55 | 0.220 |
Why?
|
| Transcription, Genetic | 3 | 2015 | 592 | 0.210 |
Why?
|
| Radiation Injuries | 1 | 2024 | 23 | 0.210 |
Why?
|
| Mevalonic Acid | 2 | 2015 | 12 | 0.200 |
Why?
|
| BRCA2 Protein | 1 | 2024 | 50 | 0.200 |
Why?
|
| BRCA1 Protein | 1 | 2024 | 58 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2025 | 213 | 0.200 |
Why?
|
| Down-Regulation | 2 | 2012 | 456 | 0.200 |
Why?
|
| Protein Footprinting | 1 | 2003 | 1 | 0.200 |
Why?
|
| Protein Kinase C | 1 | 2003 | 124 | 0.190 |
Why?
|
| Chromatography, Affinity | 1 | 2003 | 68 | 0.190 |
Why?
|
| Protein Transport | 2 | 2015 | 296 | 0.180 |
Why?
|
| Phthalazines | 1 | 2021 | 4 | 0.180 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 74 | 0.180 |
Why?
|
| Mice, Nude | 2 | 2020 | 408 | 0.170 |
Why?
|
| K562 Cells | 3 | 2006 | 32 | 0.160 |
Why?
|
| Oligonucleotides | 1 | 2020 | 49 | 0.160 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2019 | 21 | 0.160 |
Why?
|
| Gene Silencing | 2 | 2011 | 154 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2012 | 56 | 0.150 |
Why?
|
| Blotting, Northern | 2 | 2013 | 150 | 0.150 |
Why?
|
| Phenotype | 2 | 2015 | 780 | 0.150 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2020 | 110 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2019 | 83 | 0.150 |
Why?
|
| History, 20th Century | 1 | 2019 | 121 | 0.150 |
Why?
|
| DNA Primers | 2 | 2014 | 294 | 0.150 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 199 | 0.140 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 74 | 0.140 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 107 | 0.140 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 121 | 0.140 |
Why?
|
| E2F1 Transcription Factor | 1 | 2017 | 22 | 0.130 |
Why?
|
| Retinoblastoma Protein | 1 | 2017 | 29 | 0.130 |
Why?
|
| Cell Survival | 2 | 2015 | 945 | 0.130 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2017 | 47 | 0.130 |
Why?
|
| Mitosis | 1 | 2017 | 114 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 33 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 45 | 0.110 |
Why?
|
| Isotope Labeling | 1 | 2015 | 26 | 0.110 |
Why?
|
| Rad51 Recombinase | 1 | 2015 | 7 | 0.110 |
Why?
|
| Phosphoserine | 1 | 2015 | 21 | 0.110 |
Why?
|
| Protein Stability | 1 | 2015 | 48 | 0.110 |
Why?
|
| Neoplasm Metastasis | 2 | 2014 | 237 | 0.110 |
Why?
|
| Flow Cytometry | 2 | 2008 | 411 | 0.110 |
Why?
|
| Cytoplasm | 1 | 2015 | 154 | 0.110 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 105 | 0.110 |
Why?
|
| Autophagy | 2 | 2012 | 140 | 0.110 |
Why?
|
| Aged | 2 | 2018 | 8214 | 0.110 |
Why?
|
| Germ Cells | 1 | 2014 | 74 | 0.100 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 118 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 127 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 196 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 224 | 0.100 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2012 | 5 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 4 | 2015 | 526 | 0.100 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 458 | 0.100 |
Why?
|
| Doxycycline | 1 | 2012 | 32 | 0.090 |
Why?
|
| Proteomics | 1 | 2015 | 378 | 0.090 |
Why?
|
| Cell Division | 2 | 2003 | 311 | 0.090 |
Why?
|
| Oligopeptides | 1 | 2012 | 109 | 0.090 |
Why?
|
| Middle Aged | 2 | 2018 | 12222 | 0.090 |
Why?
|
| Adult | 3 | 2018 | 13872 | 0.090 |
Why?
|
| Models, Biological | 1 | 2015 | 712 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 183 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 934 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2014 | 273 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1271 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2853 | 0.070 |
Why?
|
| Cross-Linking Reagents | 1 | 2008 | 51 | 0.070 |
Why?
|
| Etoposide | 1 | 2008 | 21 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 140 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 314 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2008 | 241 | 0.060 |
Why?
|
| Leukemia, Myeloid | 1 | 2006 | 7 | 0.060 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2008 | 134 | 0.060 |
Why?
|
| Homozygote | 1 | 2005 | 77 | 0.060 |
Why?
|
| Lipogenesis | 1 | 2025 | 19 | 0.060 |
Why?
|
| Genotype | 1 | 2008 | 800 | 0.060 |
Why?
|
| Ubiquitination | 1 | 2025 | 62 | 0.050 |
Why?
|
| Base Sequence | 2 | 2004 | 983 | 0.050 |
Why?
|
| Dactinomycin | 1 | 2003 | 11 | 0.050 |
Why?
|
| Phorbol Esters | 1 | 2003 | 8 | 0.050 |
Why?
|
| Protein Kinase C-delta | 1 | 2003 | 17 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2003 | 43 | 0.050 |
Why?
|
| Phospholipase D | 1 | 2004 | 49 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2024 | 46 | 0.050 |
Why?
|
| Luciferases | 1 | 2003 | 71 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 165 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2004 | 1621 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 134 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 665 | 0.050 |
Why?
|
| Transfection | 1 | 2003 | 532 | 0.050 |
Why?
|
| Cell Line | 2 | 2004 | 1410 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2006 | 876 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 508 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 734 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1124 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2002 | 185 | 0.040 |
Why?
|
| Inflammation | 1 | 2024 | 758 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2015 | 60 | 0.030 |
Why?
|
| Nucleosomes | 1 | 2015 | 30 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 65 | 0.030 |
Why?
|
| Osmotic Pressure | 1 | 2014 | 22 | 0.030 |
Why?
|
| Elasticity | 1 | 2014 | 53 | 0.030 |
Why?
|
| Cell Size | 1 | 2014 | 46 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2015 | 416 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 98 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2012 | 3 | 0.020 |
Why?
|
| Prenylation | 1 | 2012 | 4 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2014 | 403 | 0.020 |
Why?
|
| Simvastatin | 1 | 2012 | 29 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 74 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 89 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2015 | 735 | 0.020 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2008 | 29 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2008 | 281 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 465 | 0.020 |
Why?
|
| Nucleotides | 1 | 2004 | 37 | 0.010 |
Why?
|
| Sp1 Transcription Factor | 1 | 2004 | 46 | 0.010 |
Why?
|
| Age of Onset | 1 | 2004 | 114 | 0.010 |
Why?
|
| Half-Life | 1 | 2004 | 63 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2004 | 206 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2004 | 91 | 0.010 |
Why?
|
| Drosophila | 1 | 2004 | 152 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 137 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 1542 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 3735 | 0.010 |
Why?
|
| Male | 1 | 2004 | 23409 | 0.000 |
Why?
|